ML15300A456

Northwest Medical Isotopes, LLC Notice of Intent to Prepare an Environmental Impact Statement and Conduct Scoping Process for Proposed Radioisotope Production Facility

ML15300A456
Person / Time
Site:	Northwest Medical Isotopes
Issue date:	11/12/2015
From:	Martinez N B, Wrona D J Division of License Renewal
To:	Haass C C Northwest Medical Isotopes
Nancy Martinez, 415-2719
Shared Package
ML15300A363	List: ML15300A456 ML15300A468
References
DLR-15-0498
Download: ML15300A456 (4)

Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 12, 2015

Carolyn C. Haass Vice President Northwest Medical Isotopes, LLC 8815 Northwest 9th Street, Suite 256

Corvallis, OR 97330

SUBJECT:

NORTHWEST MEDICAL ISOTOPES, LLC NOTICE OF INTENT TO PREPARE AN ENVIRONMENTAL IMPACT STATEMENT AND CONDUCT SCOPING PROCESS FOR PROPOSED RADIOISOTOPE PRODUCTION FACILITY

Dear Ms. Haass:

The U.S. Nuclear Regulatory Commission staff (NRC or the staff) has received your application for a construction permit for a radioisotope production facility. In support of the application, Northwest Medical Isotopes, LLC (NWMI) also submitted an environmental report for the radioisotope production facility. This letter provides information related to the staff's environmental review of the application.

The NRC has prepared a notice of intent advising the public that the NRC intends to gather information necessary to prepare an Environmental Impact Statement related to the review of the application for the construction permit. Enclosed is a copy of the Notice of Intent, which has been forwarded to the Office of the Federal Register for publication.

Pursuant to Title 10 of Code of Federal Regulations (10 CFR), Section 51.28, NWMI is invited to participate in the environmental scoping process. As discussed in the enclosed notice, the staff is providing the public with the opportunity to participate in an environmental scoping meeting to be held on December 8, 2015. The meeting will be held at the Holiday Inn Columbia-East, 915 Port Way, Columbia, MO 65201. The meeting will begin with an open house from 5:00 p.m. until 6:00 p.m., followed by an NRC staff presentation and opportunity to hear public comments

from 6:00 p.m. until 8:00 p.m. The NRC will present an overview of the environmental review process and will describe how the process will be implemented for the review of the NWMI Construction Permit application.

A separate NRC meeting notice with a more detailed agenda is forthcoming. You will be

provided a copy of that notice.

Should you have any questions regarding t he scoping meeting, please contact the NRC's Environmental Project Manager, Nancy Martinez, at 301-415-2719 or by e-mail at Nancy.Martinez@nrc.gov. Sincerely,

/RA/ David J. Wrona, Chief Environmental Review

and Guidance Update Branch Division of License Renewal Office of Nuclear Reactor Regulation

Docket No. 50-609

Enclosure:

Federal Register Notice cc w/encl: Distribution

ML (Pkg) ML15300A363 ML (Ltr) ML15300A456 ML (FRN) ML15300A468 *concurred via email

SUBJECT:

NORTHWEST MEDICAL ISOTOPES, LLC NOTICE OF INTENT TO PREPARE AN ENVIRONMENTAL IMPACT STATEMENT AND CONDUCT SCOPING PROCESS FOR PROPOSED RADIOISOTOPE PRODUCTION FACILITY

DISTRIBUTION E-mail: Public AAdams, NRR DTiktinsky, NMSS RidsOgcMailCenter SLynch, NRR RJohnson, NMSS RidsNrrDpr DBarass, NSIR ASapountzis, NSIR RidsNrrDprPrta LTran, NRR LHarris, NSIR RidsNrrDprPrtb MYoung, OGC DWrona, NRR RidsAcrsAcnw_MailCTR NMartinez, NRR MBalazik, NRR MMoser, NRR Hard Copy:

Englewood, Colorado, 80112 Nicholas F. Fowler

Chief Executive Officer Northwest Medical Isotopes, LLC 8815 Northwest 9th Street, Suite 256

Corvallis, OR 97330

Darrell Liles, CHP, PE Senior Health Physicist ARCADIS-SENES 8310 South Valley Highway Suite 135 UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 12, 2015

Carolyn C. Haass Vice President Northwest Medical Isotopes, LLC 8815 Northwest 9th Street, Suite 256

Corvallis, OR 97330

SUBJECT:

NORTHWEST MEDICAL ISOTOPES, LLC NOTICE OF INTENT TO PREPARE AN ENVIRONMENTAL IMPACT STATEMENT AND CONDUCT SCOPING PROCESS FOR PROPOSED RADIOISOTOPE PRODUCTION FACILITY

Dear Ms. Haass:

The U.S. Nuclear Regulatory Commission staff (NRC or the staff) has received your application for a construction permit for a radioisotope production facility. In support of the application, Northwest Medical Isotopes, LLC (NWMI) also submitted an environmental report for the radioisotope production facility. This letter provides information related to the staff's environmental review of the application.

The NRC has prepared a notice of intent advising the public that the NRC intends to gather information necessary to prepare an Environmental Impact Statement related to the review of the application for the construction permit. Enclosed is a copy of the Notice of Intent, which has been forwarded to the Office of the Federal Register for publication.

Pursuant to Title 10 of Code of Federal Regulations (10 CFR), Section 51.28, NWMI is invited to participate in the environmental scoping process. As discussed in the enclosed notice, the staff is providing the public with the opportunity to participate in an environmental scoping meeting to be held on December 8, 2015. The meeting will be held at the Holiday Inn Columbia-East, 915 Port Way, Columbia, MO 65201. The meeting will begin with an open house from 5:00 p.m. until 6:00 p.m., followed by an NRC staff presentation and opportunity to hear public comments

from 6:00 p.m. until 8:00 p.m. The NRC will present an overview of the environmental review process and will describe how the process will be implemented for the review of the NWMI Construction Permit application.

A separate NRC meeting notice with a more detailed agenda is forthcoming. You will be

provided a copy of that notice.

Should you have any questions regarding t he scoping meeting, please contact the NRC's Environmental Project Manager, Nancy Martinez, at 301-415-2719 or by e-mail at Nancy.Martinez@nrc.gov. Sincerely,

/RA/ David J. Wrona, Chief Environmental Review

and Guidance Update Branch Division of License Renewal Office of Nuclear Reactor Regulation

Docket No. 50-609

Enclosure:

Federal Register Notice cc w/encl: Distribution

ML (Pkg) ML15300A363 ML (Ltr) ML15300A456 ML (FRN) ML15300A468 *concurred via email

SUBJECT:

NORTHWEST MEDICAL ISOTOPES, LLC NOTICE OF INTENT TO PREPARE AN ENVIRONMENTAL IMPACT STATEMENT AND CONDUCT SCOPING PROCESS FOR PROPOSED RADIOISOTOPE PRODUCTION FACILITY

DISTRIBUTION E-mail: Public AAdams, NRR DTiktinsky, NMSS RidsOgcMailCenter SLynch, NRR RJohnson, NMSS RidsNrrDpr DBarass, NSIR ASapountzis, NSIR RidsNrrDprPrta LTran, NRR LHarris, NSIR RidsNrrDprPrtb MYoung, OGC DWrona, NRR RidsAcrsAcnw_MailCTR NMartinez, NRR MBalazik, NRR MMoser, NRR Hard Copy:

Englewood, Colorado, 80112 Nicholas F. Fowler

Chief Executive Officer Northwest Medical Isotopes, LLC 8815 Northwest 9th Street, Suite 256

Corvallis, OR 97330

Darrell Liles, CHP, PE Senior Health Physicist ARCADIS-SENES 8310 South Valley Highway Suite 135